Artykuły w czasopismach na temat „GLS1”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „GLS1”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Vidula, Neelima, Christina Yau i Hope S. Rugo. "Glutaminase (GLS) expression in primary breast cancer (BC): Correlations with clinical and tumor characteristics." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 558. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.558.
Pełny tekst źródłaRojas, Livisu Pajares, i Claudia Machicado Rivero. "Abstract 883: Glutaminases expression and viral infection as potential prognostic factors in cervical, head and neck and liver cancers". Cancer Research 83, nr 7_Supplement (4.04.2023): 883. http://dx.doi.org/10.1158/1538-7445.am2023-883.
Pełny tekst źródłaBright, Scott J., Rishab Kolachina, Mariam Ben Kacem, Mandira Manandhar, Philip Jones, Timothy A. Yap, Steven H. Lin i Gabriel O. Sawakuchi. "Abstract B030: Modulating mitochondria metabolism to radiosensitize KEAP1 mutated non-small cell lung cancer". Cancer Research 84, nr 1_Supplement (9.01.2024): B030. http://dx.doi.org/10.1158/1538-7445.dnarepair24-b030.
Pełny tekst źródłaXiao, Yangbo, Rong Huang, Shenping Cao, Dafang Zhao, Zhuangwen Mao, Chuchu Xiao, Zhehua Xu i in. "Molecular Characterization and Dietary Regulation of Glutaminase 1 (gls1) in Triploid Crucian Carp (Carassius auratus)". Fishes 7, nr 6 (7.12.2022): 377. http://dx.doi.org/10.3390/fishes7060377.
Pełny tekst źródłaMyint, Zin W., Ramon C. Sun, Patrick J. Hensley, Andrew C. James, Peng Wang, Stephen E. Strup, Robert J. McDonald, Donglin Yan, William H. St. Clair i Derek B. Allison. "Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters". Cancers 13, nr 9 (29.04.2021): 2157. http://dx.doi.org/10.3390/cancers13092157.
Pełny tekst źródłaYang, Jianqiang, Fanghui Chen, Fan Yang i Yong Teng. "Abstract 3061: A positive feedback loop between GLS1 and c-Myc drives tumor aggressiveness". Cancer Research 84, nr 6_Supplement (22.03.2024): 3061. http://dx.doi.org/10.1158/1538-7445.am2024-3061.
Pełny tekst źródłaAhmed, Shanzay, Peter John, Rehan Zafar Paracha, Attya Bhatti i Monica Guma. "Docking and Molecular Dynamics Study to Identify Novel Phytobiologics from Dracaena trifasciata against Metabolic Reprogramming in Rheumatoid Arthritis". Life 12, nr 8 (29.07.2022): 1148. http://dx.doi.org/10.3390/life12081148.
Pełny tekst źródłaKono, Michihito, Nobuya Yoshida, Kayaho Maeda i George C. Tsokos. "Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells". Proceedings of the National Academy of Sciences 115, nr 10 (20.02.2018): 2478–83. http://dx.doi.org/10.1073/pnas.1714717115.
Pełny tekst źródłaBeręsewicz-Haller, Małgorzata, Olga Krupska, Paweł Bochomulski, Danuta Dudzik, Anita Chęcińska, Wojciech Hilgier, Coral Barbas, Krzysztof Zablocki i Barbara Zablocka. "Mitochondrial Metabolism behind Region-Specific Resistance to Ischemia-Reperfusion Injury in Gerbil Hippocampus. Role of PKCβII and Phosphate-Activated Glutaminase". International Journal of Molecular Sciences 22, nr 16 (7.08.2021): 8504. http://dx.doi.org/10.3390/ijms22168504.
Pełny tekst źródłaMyint, Zin, Patrick J. Hensley, Andrew Callaway James, Peng Wang, Stephen Strup, Donglin Yan, William H. St Clair, Robert S. DiPaola i Derek B. Allison. "Immunohistochemical evaluation of glutaminase expression in prostate adenocarcinoma and correlation with clinicopathologic parameters." Journal of Clinical Oncology 39, nr 6_suppl (20.02.2021): 251. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.251.
Pełny tekst źródłaSyarifin, Andi N. K., Sri W. A. Jusman i Mohamad Sadikin. "Gene expression and enzyme activities of carbonic anhydrase and glutaminase in rat kidneys induced by chronic systemic hypoxia". Medical Journal of Indonesia 24, nr 3 (9.11.2015): 139–45. http://dx.doi.org/10.13181/mji.v24i3.1190.
Pełny tekst źródłaHage, Maha El, Justine Masson, Agnès Conjard-Duplany, Bernard Ferrier, Gabriel Baverel i Guy Martin. "Brain Slices from Glutaminase-Deficient Mice Metabolize Less Glutamine: A Cellular Metabolomic Study with Carbon 13 NMR". Journal of Cerebral Blood Flow & Metabolism 32, nr 5 (29.02.2012): 816–24. http://dx.doi.org/10.1038/jcbfm.2012.22.
Pełny tekst źródłaAkar, Hamurcu i Donmez-Altuntas. "The Effects on Proliferation of siRNA-Mediated GLS1 Inhibition in MDA-MB 231 Breast Cancer Cells". Proceedings 40, nr 1 (26.12.2019): 25. http://dx.doi.org/10.3390/proceedings2019040025.
Pełny tekst źródłaFu, Jiayao, Yiping Pu, Baoli Wang, Hui Li, Xiujuan Yang, Lisong Xie, Huan Shi i in. "Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren’s Syndrome". Journal of Immunology Research 2022 (15.02.2022): 1–13. http://dx.doi.org/10.1155/2022/3210200.
Pełny tekst źródłaCoen, Chad, Jizhi Yan, Caner Saygin, Nicole Arellano, Mirielle Nauman, Katarzyna Zawieracz, Daniele Vanni i in. "Glutamine Metabolism Is Altered in Myeloproliferative Neoplasms and Represents a Potential Novel Therapeutic Target". Blood 142, Supplement 1 (28.11.2023): 6350. http://dx.doi.org/10.1182/blood-2023-189731.
Pełny tekst źródłaYoshikawa, Sachiko, Manabu Nagao, Ryuji Toh, Masakazu Shinohara, Takuya Iino, Yasuhiro Irino, Makoto Nishimori i in. "Inhibition of glutaminase 1-mediated glutaminolysis improves pathological cardiac remodeling". American Journal of Physiology-Heart and Circulatory Physiology 322, nr 5 (1.05.2022): H749—H761. http://dx.doi.org/10.1152/ajpheart.00692.2021.
Pełny tekst źródłaFeng, Yifan, Xi Yang, Jinhai Huang, Minqian Shen, Liyang Wang, Xiuping Chen, Yuanzhi Yuan, Chunqiong Dong, Xiaoping Ma i Fei Yuan. "Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages". Oxidative Medicine and Cellular Longevity 2022 (19.03.2022): 1–19. http://dx.doi.org/10.1155/2022/1106313.
Pełny tekst źródłaXu, Lingfan, Yu Yin, Yanjing Li, Xufeng Chen, Yan Chang, Hong Zhang, Juan Liu i in. "A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer". Proceedings of the National Academy of Sciences 118, nr 13 (22.03.2021): e2012748118. http://dx.doi.org/10.1073/pnas.2012748118.
Pełny tekst źródłaShibuya, Aya, Neil Margulis, Romain Christiano, Tobias C. Walther i Charles Barlowe. "The Erv41–Erv46 complex serves as a retrograde receptor to retrieve escaped ER proteins". Journal of Cell Biology 208, nr 2 (12.01.2015): 197–209. http://dx.doi.org/10.1083/jcb.201408024.
Pełny tekst źródłaXiong, Jian, Thi Thu Trang Luu, Kartik Venkatachalam, Guangwei Du i Michael X. Zhu. "Glutamine Produces Ammonium to Tune Lysosomal pH and Regulate Lysosomal Function". Cells 12, nr 1 (24.12.2022): 80. http://dx.doi.org/10.3390/cells12010080.
Pełny tekst źródłaAbdel-Magid, Ahmed F. "Glutaminase GLS1 Inhibitors as Potential Cancer Treatment". ACS Medicinal Chemistry Letters 7, nr 3 (luty 2016): 207–8. http://dx.doi.org/10.1021/acsmedchemlett.6b00016.
Pełny tekst źródłaGuba, B. S., i V. V. Lyubimov. "Relationship between the effective saturation energy and the amplification diagram of GLS1 and GLS2 neodymium glasses". Soviet Journal of Quantum Electronics 20, nr 9 (30.09.1990): 1075–78. http://dx.doi.org/10.1070/qe1990v020n09abeh007407.
Pełny tekst źródłaLee, You Won, Hun Mi Choi, Seung Yeon Oh, Eun Ji Lee, Kyoung-Ho Pyo, Jae Hwan Kim, Youngseon Byeon i in. "Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs". Cancer Research 82, nr 12_Supplement (15.06.2022): LB544. http://dx.doi.org/10.1158/1538-7445.am2022-lb544.
Pełny tekst źródłaJovanovic, Katarina K., Léa Fléchon, Mairead Reidy, Jihye Park, Xavier Leleu, Irene M. Ghobrial, Thierry Facon, Bruno Quesnel i Salomon Manier. "MYC Overexpressing Multiple Myeloma Are Dependent on GLS1". Blood 134, Supplement_1 (13.11.2019): 853. http://dx.doi.org/10.1182/blood-2019-128484.
Pełny tekst źródłaRojo-Báez, Indira, Raymundo S. García-Estrada, Josefina León-Félix, J. Adriana Sañudo-Barajas i Raúl Allende-Molar. "EXPRESIÓN GÉNICA DURANTE EL PROCESO DE INFECCIÓN DE Colletotrichum truncatum (SCHWEIN.) EN PAPAYA MARADOL". Revista Fitotecnia Mexicana 44, nr 2 (28.06.2021): 221. http://dx.doi.org/10.35196/rfm.2021.2.221.
Pełny tekst źródłaSponagel, Jasmin, Shanshan Zhang, Prakash Chinnaiyan, Joshua Rubin i Joseph Ippolito. "TBIO-01. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_3 (1.12.2020): iii467. http://dx.doi.org/10.1093/neuonc/noaa222.830.
Pełny tekst źródłaLiu, Haixin, Haolun Tian, Pengcheng Hao, Huimin Du, Kun Wang, Yudong Qiu, Xiangrui Yin i in. "PoRVA G9P[23] and G5P[7] infections differentially promote PEDV replication by reprogramming glutamine metabolism". PLOS Pathogens 20, nr 6 (21.06.2024): e1012305. http://dx.doi.org/10.1371/journal.ppat.1012305.
Pełny tekst źródłaKim, Sewha, Do Hee Kim, Woo-Hee Jung i Ja Seung Koo. "Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer". Endocrine-Related Cancer 20, nr 3 (18.03.2013): 339–48. http://dx.doi.org/10.1530/erc-12-0398.
Pełny tekst źródłaSponagel, Jasmin, Shanshan Zhang, Cheryl Frankfater, Jill Jones, Din Selmanovic, Prakash Chinnaiyan, Joshua B. Rubin i Joseph E. Ippolito. "FSMP-19. SEX DIFFERENCES IN REDOX REGULATION UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology Advances 3, Supplement_1 (1.03.2021): i19—i20. http://dx.doi.org/10.1093/noajnl/vdab024.082.
Pełny tekst źródłaChattopadhyaya, Sikta, Raghu Nagalingam, Pavit Narhan i Michael Czubryt. "Regulation of GLS1 Expression by Scleraxis in Cardiac Fibroblasts". FASEB Journal 34, S1 (kwiecień 2020): 1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.05913.
Pełny tekst źródłaXia, Xichun, Guangchao Cao, Guodong Sun, Leqing Zhu, Yixia Tian, Yueqi Song, Chengbin Guo i in. "GLS1-mediated glutaminolysis unbridled by MALT1 protease promotes psoriasis pathogenesis". Journal of Clinical Investigation 130, nr 10 (24.08.2020): 5180–96. http://dx.doi.org/10.1172/jci129269.
Pełny tekst źródłaChen, Weihua, Weifeng Wang, Jun Zhang, Guoqiang Liao, Jie Bai, Bo Yang, Mingyue Tan i Hua Gong. "Qici Sanling Decoction Suppresses Glutamine Consumption and Bladder Cancer Cell Growth through Inhibiting c-Myc Expression". Journal of Oncology 2022 (11.01.2022): 1–9. http://dx.doi.org/10.1155/2022/7985468.
Pełny tekst źródłaKrishna, Gayathri, Vinod Soman Pillai i Mohanan Valiya Veettil. "Upregulation of GLS1 Isoforms KGA and GAC Facilitates Mitochondrial Metabolism and Cell Proliferation in Epstein–Barr Virus Infected Cells". Viruses 12, nr 8 (27.07.2020): 811. http://dx.doi.org/10.3390/v12080811.
Pełny tekst źródłaNaka, I., J. Saegusa, K. Uto, Y. Yamamoto, Y. Ichise, H. Yamada, K. Akashi i in. "SAT0011 COMBINED INHIBITION OF AUTOPHAGY AND GLUTAMINE METABOLISM SUPPRESSES CELL GROWTH OF RA SYNOVIOCYTES AND AMELIORATES ARTHRITIS IN SKG MICE". Annals of the Rheumatic Diseases 79, Suppl 1 (czerwiec 2020): 935.2–936. http://dx.doi.org/10.1136/annrheumdis-2020-eular.1661.
Pełny tekst źródłaPoonaki, Elham, Ann-Christin Nickel, Mehdi Shafiee Ardestani, Lars Rademacher, Marilyn Kaul, Evgeny Apartsin, Sven G. Meuth, Ali Gorji, Christoph Janiak i Ulf Dietrich Kahlert. "CD133-Functionalized Gold Nanoparticles as a Carrier Platform for Telaglenastat (CB-839) against Tumor Stem Cells". International Journal of Molecular Sciences 23, nr 10 (13.05.2022): 5479. http://dx.doi.org/10.3390/ijms23105479.
Pełny tekst źródłaXu, Kangdi, Jun Ding, Lingfeng Zhou, Dazhi Li, Jia Luo, Wenchao Wang, Mingge Shang, Bingyi Lin, Lin Zhou i Shusen Zheng. "SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis". Cells 12, nr 1 (21.12.2022): 25. http://dx.doi.org/10.3390/cells12010025.
Pełny tekst źródłaLang, Liwei, Fang Wang, Chloe Shay, Yonggang Ke, Nabil Saba i Yong Teng. "Abstract 3026: Inhibition of glutaminolysis overcomes metabolic adaptation to devimistat treatment". Cancer Research 82, nr 12_Supplement (15.06.2022): 3026. http://dx.doi.org/10.1158/1538-7445.am2022-3026.
Pełny tekst źródłaOzcan, Selahattin C., Aydan Mutlu, Tugba H. Altunok, Yunus Gurpinar, Aybike Sarioglu, Sabire Guler, Robertino J. Muchut i in. "Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells". Biochemical and Biophysical Research Communications 571 (wrzesień 2021): 118–24. http://dx.doi.org/10.1016/j.bbrc.2021.07.070.
Pełny tekst źródłaXi, Jianbo, Yaocheng Sun, Meiting Zhang, Zhenzhong Fa, Yanya Wan, Zhenyu Min, Hong Xu, Chengkai Xu i Jianjun Tang. "GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway". Experimental Cell Research 381, nr 1 (sierpień 2019): 1–9. http://dx.doi.org/10.1016/j.yexcr.2019.04.005.
Pełny tekst źródłaJo, Michiko, Keiichi Koizumi, Mizuho Suzuki, Daisuke Kanayama, Yurie Watanabe, Hiroaki Gouda, Hisashi Mori i in. "Design, synthesis, structure–activity relationship studies, and evaluation of novel GLS1 inhibitors". Bioorganic & Medicinal Chemistry Letters 87 (maj 2023): 129266. http://dx.doi.org/10.1016/j.bmcl.2023.129266.
Pełny tekst źródłaOkada, Takuya, Kaho Yamabe, Michiko Jo, Yuko Sakajiri, Tomokazu Shibata, Ryusuke Sawada, Yoshihiro Yamanishi i in. "Design and structural optimization of thiadiazole derivatives with potent GLS1 inhibitory activity". Bioorganic & Medicinal Chemistry Letters 93 (wrzesień 2023): 129438. http://dx.doi.org/10.1016/j.bmcl.2023.129438.
Pełny tekst źródłaLam, Elaine T., Lih-Jen Su, Maren Salzmann-Sullivan, Steven K. Nordeen i Thomas W. Flaig. "Preclinical evaluation of teleglenastat (CB-839) in prostate cancer." Journal of Clinical Oncology 41, nr 6_suppl (20.02.2023): 378. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.378.
Pełny tekst źródłaLi, Lingzhi, Changying Jiang, Lucy Jayne Navsaria, Yang Liu, Angela Leeming, Michael Wang i Yixin Yao. "Targeting Glutamine Metabolism Overcomes Resistance to Targeted Therapies in Refractory Mantle Cell Lymphoma". Blood 136, Supplement 1 (5.11.2020): 25–26. http://dx.doi.org/10.1182/blood-2020-140736.
Pełny tekst źródłaMoncada, Salvador, E. Annie Higgs i Sergio L. Colombo. "Fulfilling the metabolic requirements for cell proliferation". Biochemical Journal 446, nr 1 (27.07.2012): 1–7. http://dx.doi.org/10.1042/bj20120427.
Pełny tekst źródłaMatre, Polina, Ismael Samudio, Rodrigo Jacamo, Ying Wang, Jing Wang, R. Eric Davis, Xiaohua Su i in. "Unraveling The Molecular and Metabolic Basis For Glutamine Addiction In Leukemias". Blood 122, nr 21 (15.11.2013): 606. http://dx.doi.org/10.1182/blood.v122.21.606.606.
Pełny tekst źródłaWu, Shuai, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu i in. "Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma". Nature Cancer 2, nr 2 (11.01.2021): 189–200. http://dx.doi.org/10.1038/s43018-020-00160-x.
Pełny tekst źródłaCai, Wei-Feng, Cixiong Zhang, Yu-Qing Wu, Gui Zhuang, Zhiyun Ye, Chen-Song Zhang i Sheng-Cai Lin. "Glutaminase GLS1 senses glutamine availability in a non-enzymatic manner triggering mitochondrial fusion". Cell Research 28, nr 8 (22.06.2018): 865–67. http://dx.doi.org/10.1038/s41422-018-0057-z.
Pełny tekst źródłaGao, Chuan-Cheng, Qin-Qin Xu, Feng-Jun Xiao, Hua Wang, Chu-Tse Wu i Li-Sheng Wang. "NUDT21 suppresses the growth of small cell lung cancer by modulating GLS1 splicing". Biochemical and Biophysical Research Communications 526, nr 2 (maj 2020): 431–38. http://dx.doi.org/10.1016/j.bbrc.2020.03.089.
Pełny tekst źródłaHenry, Christophe, Dimitri Gorge-Bernat, Pascal Pannier, Isabelle Meaux, Jane Cheng, Fangxian Sun, Olivier Pasquier i in. "Abstract 6033: RA123, a new GLS1 allosteric inhibitor demonstrates in vitro and in vivo activity in multiple myeloma models". Cancer Research 83, nr 7_Supplement (4.04.2023): 6033. http://dx.doi.org/10.1158/1538-7445.am2023-6033.
Pełny tekst źródłaSponagel, Jasmin, Shanshan Zhang, Jill Jones, Prakash Chinnaiyan, Joshua Rubin i Joseph Ippolito. "TAMI-37. SEX DIFFERENCES IN REDOX STATE UNDERLIE GLUTAMINE DEPENDENCY IN MALE GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (listopad 2020): ii221. http://dx.doi.org/10.1093/neuonc/noaa215.925.
Pełny tekst źródła